1. Signaling Pathways
  2. Cell Cycle/DNA Damage
    Cytoskeleton
  3. Kinesin
  4. Kinesin-7/CENP-E Isoform

Kinesin-7/CENP-E

CENP-E/KIF10 is a kinesin-7 kinetochore motor that positions chromosomes at the metaphase plate and supports kinetochore-microtubule attachment during mitosis[1][2]. Mechanistically, CENP-E acts in chromosome congression, bioriented spindle attachment, and spindle assembly checkpoint control, because CENP-E loss produces aligned and unaligned chromosomes with mitotic arrest[2][3]. CENP-E also behaves as a processive microtubule plus-end motor and a bidirectional tracker of dynamic microtubule tips, linking chromosome movement with stable kinetochore-microtubule end attachment[4]. In meiotic models, CENP-E inhibition or depletion causes chromosome misalignment, metaphase arrest, spindle elongation, spindle disorganization, and chromosome instability in mouse spermatocytes[5]. Compared with related mitotic motors, Kid and CENP-E make different contributions to chromosome congression, and CENP-E can suppress congression when microtubules remain short and unstable[6]. Recent cancer-cell data further distinguish CENP-E from KIF18A, because KIF18A promotes chromosome congression in cooperation with CENP-E downstream of CENP-C[7]. For experimental applications, GSK923295 inhibits CENP-E ATPase activity, locks the motor domain on microtubules, disrupts metaphase chromosome alignment, induces mitotic arrest, and supports aneuploidy-generation assays[8][9].

References:

Kinesin-7/CENP-E Related Products (5):

Cat. No. Product Name Effect Purity
  • HY-10299
    GSK-923295
    Inhibitor 99.95%
    GSK-923295 is a special, allosteric inhibitor of centromere-associated protein-E (CENP-E) kinesin motor ATPase activity, with Ki of 3.2±0.2 nM and 1.6± 0.1 nM for human and canine, respectively.
  • HY-19530
    PF-2771
    Inhibitor 99.66%
    PF-2771 is a potent and selective centromere protein E (CENP-E) inhibitor, inhibiting CENP-E motor activity with an IC50 of 16.1 nM; PF-2771 is used as an anticancer agent.
  • HY-121569
    Syntelin
    Inhibitor 98.25%
    Syntelin is a selective centromere protein E (CENP-E) inhibitor with IC50 at 160 nM. Syntelin has antitumor activity.
  • HY-161897
    CENP-E-IN-2
    Inhibitor
    CENP-E-IN-2 (compound 3) is a photoswitchable CENP-E inhibitor, with the pIC50 of 6.82 without light illumination and 5.85 with 365 nm light illumination. CENP-E-IN-2 has antitumor activity.
  • HY-161898
    CENP-E-IN-3
    Inhibitor
    CENP-E-IN-3 (compound 4) is a potent CENP-E inhibitor. CENP-E-IN-3 has the potential for the research of cancer.